Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy

BACKGROUND: Associations between candidate genetic variants and treatment outcomes of oxaliplatin, a drug commonly used for colorectal cancer patients, have been reported but not robustly established. This study aimed to validate previously reported prognostic and predictive genetic markers for oxal...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hanla A., Seibold, Petra, Edelmann, Dominic, Benner, Axel, Canzian, Federico, Alwers, Elizabeth, Jansen, Lina, Schneider, Martin, Hoffmeister, Michael, Brenner, Hermann, Chang-Claude, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789680/
https://www.ncbi.nlm.nih.gov/pubmed/34862210
http://dx.doi.org/10.1158/1055-9965.EPI-21-0814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789680/
https://www.ncbi.nlm.nih.gov/pubmed/34862210
http://dx.doi.org/10.1158/1055-9965.EPI-21-0814

Ejemplares similares